4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001209191-14-013598
CIK 0001373707operating
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:31 PM ET
Size
5.3 KB
Accession
0001209191-14-013598
Insider Transaction Report
Form 4
Sutcliffe Joyce A.
Senior Vice President, Biology
Transactions
- Sale
Common Stock
2014-02-20$14.00/sh−11,494$160,916→ 28,736 total
Footnotes (2)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2013.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.92 to $14.14 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:31 PM ET
- Size
- 5.3 KB